| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,145,000 | 3,123,000 | 2,824,000 | 3,131,000 | | Cost of Revenue | 1,513,000 | 1,485,000 | 1,336,000 | 1,529,000 | | | Gross Profit | 1,632,000 | 1,638,000 | 1,488,000 | 1,602,000 | | | Operating Expenses | | Research Development | 228,000 | 231,000 | 212,000 | 226,000 | | Selling General and Administrative | 672,000 | 660,000 | 611,000 | 681,000 | | Non Recurring |
-
|
-
|
-
| 15,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 732,000 | 747,000 | 665,000 | 680,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (61,000) | 6,000 | 3,000 | 67,000 | | Earnings Before Interest And Taxes | 598,000 | 872,000 | 549,000 | 722,000 | | Interest Expense | (60,000) | 29,000 | 31,000 | 35,000 | | Income Before Tax | 658,000 | 843,000 | 518,000 | 687,000 | | Income Tax Expense | 126,000 | 135,000 | 119,000 | 118,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 526,000 | 589,000 | 518,000 | 569,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 526,000 | 589,000 | 518,000 | 569,000 | | Preferred Stock And Other Adjustments | 4,000 | (2,000) | (2,000) |
-
| | | Net Income Applicable To Common Shares | $530,000 | $587,000 | $516,000 | $569,000 |
|
0.20% Nasdaq 
0.14%
Income Statement
